B6.129P2-Mmp19tm1Rase/Ph

Status

Available to order

EMMA IDEM:06786
Citation informationRRID:IMSR_EM:06786 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameB6.129P2-Mmp19tm1Rase/Ph
Alternative nameB6.MMP19
Strain typeTargeted Mutant Strains : Knock-out
Allele/Transgene symbolMmp19tm1Rase
Gene/Transgene symbolMmp19

Information from provider

ProviderRadislav Sedlacek
Provider affiliationDepartment of Transgenic Models of Diseases, Institute of Molecular Genetics
Genetic informationA targeting construct based on pPNT vector was generated by replacement of 1088 bp region of MMP19 gene spanning the end of exon 3 and the whole exon 4 encoding the catalytic domain by the neomycin resistance cassette.
Phenotypic informationa) MMP19-/- mice show reduced inflammatory reactions in the skin. Immature knockout mice have delayed development of thymocyte. b) MMP-19-deficiency reduces the extent of hepatocellular injury and leads to faster recovery from liver fibrosis.
Breeding historyThe strain is kept on C57BL/6NCrl background and backcrossed more than 20 generations. wt x het, het x het and ko x ko matings are currently done.
References
  • MMP19 is essential for T cell development and T cell-mediated cutaneous immune responses.;Beck Inken M, Rückert René, Brandt Katja, Mueller Markus S, Sadowski Thorsten, Brauer Rena, Schirmacher Peter, Mentlein Rolf, Sedlacek Radislav, ;2008;PloS one;3;e2343; 18523579
  • Hepatoprotective effect of MMP-19 deficiency in a mouse model of chronic liver fibrosis.;Jirouskova Marketa, Zbodakova Olga, Gregor Martin, Chalupsky Karel, Sarnova Lenka, Hajduch Marian, Ehrmann Jiri, Jirkovska Marie, Sedlacek Radislav, ;2012;PloS one;7;e46271; 23056273
  • MMP-19 deficiency causes aggravation of colitis due to defects in innate immune cell function.;Brauer R, Tureckova J, Kanchev I, Khoylou M, Skarda J, Prochazka J, Spoutil F, Beck I M, Zbodakova O, Kasparek P, Korinek V, Chalupsky K, Karhu T, Herzig K-H, Hajduch M, Gregor M, Sedlacek R, ;2016;Mucosal immunology;9;974-85; 26555704
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreInstitute of Molecular Genetics, Prague, Czech Republic
Animals used for archivinghomozygous males, wild-type females
Stage of embryos2-cell

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

MGI phenotypes (allele matching)
  • abnormal T cell activation / MGI
  • decreased inflammatory response / MGI
  • abnormal T cell differentiation / MGI
  • increased double-positive T cell number / MGI
  • decreased T cell proliferation / MGI
  • decreased susceptibility to type IV hypersensitivity reaction / MGI
  • decreased CD4-positive, alpha beta T cell number / MGI
  • decreased CD8-positive, alpha-beta T cell number / MGI
  • abnormal cytokine level / MGI
MGI phenotypes (gene matching)
  • abnormal T cell activation / MGI
  • decreased inflammatory response / MGI
  • abnormal T cell differentiation / MGI
  • decreased incidence of tumors by chemical induction / MGI
  • increased double-positive T cell number / MGI
  • decreased T cell proliferation / MGI
  • abnormal fat pad morphology / MGI
  • decreased susceptibility to type IV hypersensitivity reaction / MGI
  • increased susceptibility to diet-induced obesity / MGI
  • increased fat cell size / MGI
  • decreased CD4-positive, alpha beta T cell number / MGI
  • decreased CD8-positive, alpha-beta T cell number / MGI
  • abnormal cytokine level / MGI
  • increased gonadal fat pad weight / MGI

Literature references

  • MMP19 is essential for T cell development and T cell-mediated cutaneous immune responses.;Beck Inken M, Rückert René, Brandt Katja, Mueller Markus S, Sadowski Thorsten, Brauer Rena, Schirmacher Peter, Mentlein Rolf, Sedlacek Radislav, ;2008;PloS one;3;e2343; 18523579
  • Hepatoprotective effect of MMP-19 deficiency in a mouse model of chronic liver fibrosis.;Jirouskova Marketa, Zbodakova Olga, Gregor Martin, Chalupsky Karel, Sarnova Lenka, Hajduch Marian, Ehrmann Jiri, Jirkovska Marie, Sedlacek Radislav, ;2012;PloS one;7;e46271; 23056273
  • MMP-19 deficiency causes aggravation of colitis due to defects in innate immune cell function.;Brauer R, Tureckova J, Kanchev I, Khoylou M, Skarda J, Prochazka J, Spoutil F, Beck I M, Zbodakova O, Kasparek P, Korinek V, Chalupsky K, Karhu T, Herzig K-H, Hajduch M, Gregor M, Sedlacek R, ;2016;Mucosal immunology;9;974-85; 26555704

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).